-
1
المؤلفون: Katja K.H. Aben, Carin A. Uyl-de Groot, Joan van den Bosch, Inge M. van Oort, Saskia van der Meer, Andries M. Bergman, Jules L.L.M. Coenen, Winald R. Gerritsen, Diederik M. Somford, Hans M. Westgeest, Jules Lavalaye, Alphons C.M. van den Bergh, Mathijs P. Hendriks, Maarten J. van der Doelen, Malou C.P. Kuppen, Filiz Celik, Marco B. Polee, Alphonsus J. M. van den Eertwegh
المساهمون: Medical oncology, CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, Health Technology Assessment (HTA), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Kuppen, M C, Westgeest, H M, van der Doelen, M J, van den Eertwegh, A J, Coenen, J L, Aben, K K, van den Bergh, A C, Bergman, A M, den Bosch, J V, Celik, F, Hendriks, M P, Lavalaye, J, der Meer, S V, Polee, M B, Somford, D M, van Oort, I M, Uyl-de Groot, C A & Gerritsen, W R 2020, ' Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer ', Future Oncology, vol. 16, no. 19, pp. 1371-1384 . https://doi.org/10.2217/fon-2020-0039Test
Future Oncology, 16(19), 1371-1384. Future Medicine Ltd.
Future Oncology, 16, 19, pp. 1371-1384
Future oncology, 16(19), 1371-1384. FUTURE MEDICINE LTD
Future Oncology, 16, 1371-1384مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Treatment completion, Databases, Factual, radium-223, THERAPY, RECOMMENDATIONS, Prostate cancer, DOUBLE-BLIND, 0302 clinical medicine, Aged, 80 and over, BONE METASTASES, Real world outcomes, CYCLES, General Medicine, sequencing, Middle Aged, real-world outcomes, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, TRIAL, medicine.drug, Radium, Radium-223, medicine.medical_specialty, PHASE-3, Antineoplastic Agents, Bone Neoplasms, Castration resistant, survival, Drug Administration Schedule, Double blind, EVENTS, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Radium-223 Dichloride, Aged, Retrospective Studies, Radioisotopes, Window of opportunity, business.industry, medicine.disease, EFFICACY, skeletal-related events, 030104 developmental biology, metastatic castration-resistant prostate cancer, EXPERIENCE, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b016678894ad456a0d9a4e1e94d887b8Test
https://pure.eur.nl/en/publications/f28d6113-b2c9-48d2-b4bf-904818fb828dTest -
2
المؤلفون: C Uyl de Groot, B Leeneman, Hedwig M. Blommestein, Marscha S. Holleman, H.M. Westgeest, M Franken, Marianne Luyendijk, Malou C.P. Kuppen, S. de Groot
المصدر: Value in Health. 21:S358-S359
مصطلحات موضوعية: 0301 basic medicine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, business.industry, 030220 oncology & carcinogenesis, Health Policy, Public Health, Environmental and Occupational Health, Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::836e6ac91ae885852ec8c99b4b26f98fTest
https://doi.org/10.1016/j.jval.2018.09.2143Test